Recalls / Active ingredient / Glycine

Glycine

10 FDA drug recalls involving the active ingredient “Glycine” — 4 Class I.

Date	Class	Product	Firm
2016-12-06	Class II	10% Premasol sulfite-free (Amino Acid) Injection, 2000 mL bulk package, Rx only, Baxter Healthcare Corporatio	Baxter Healthcare Corporation
2016-01-21	Class I	CLINIMIX E 5/15 sulfite-free (5% Amino Acid with Electrolytes in 15% Dextrose with Calcium) Injection, 1000 mL	Baxter Healthcare Corp.
2015-04-28	Class II	KABIVEN [(3.9%) Lipid Injectable Emulsion with (3.1%) Amino Acids and Electrolytes and (9.8%) Dextrose; Sulfit	Fresenius Kabi USA, LLC
2015-03-23	Class II	Clinimix E 5/20 sulfite-free (5% amino-acid with electrolytes in 20% dextrose with calcium) Injection, 2000 mL	Baxter Healthcare Corp
2014-11-25	Class II	Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections,	Baxter Healthcare Corp.
2014-08-04	Class II	ProSol - sulfite-free (Amino Acid) Injection, 20%, 2000 mL VIAFLEX container bag, Rx only, Baxter Healthcare C	Baxter Healthcare Corp
2013-11-18	Class I	Clinimix 4.25/25 sulfite-free (4.25% Amino Acid in 25% Dextrose) Injection, 1000 mLCLARITY Dual Chamber Contai	Baxter Healthcare Corp.
2013-11-18	Class I	Clinimix 5/15 sulfite-free (5% Amino Acid in 15% Dextrose) Injection, 2000 mL CLARITY Dual Chamber Container b	Baxter Healthcare Corp.
2013-11-18	Class I	Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injection, 2	Baxter Healthcare Corp.
2013-11-12	Class II	10%, Travasol (Amino Acid) Injection, 2000 ml, Pharmacy Bulk Package Not for Direct Infusion, Baxter Healthcar	Baxter Healthcare Corp.